Drugs / MAGE-A1, MAGE-A3, and NY-ESO-1 Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00944580 | Jun 2009 → Aug 2010 | neuroblastoma, osteosarcoma, rhabdomyosarcoma | Penn State University | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MAGE-A1, MAGE-A3, and NY-ESO-1 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00944580 ↗ |
| Modality | Vaccine | “MAGE-A1, MAGE-A3, and NY-ESO-1 Vaccine” NCT00944580 ↗ |